CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

Autor: Zhao, Yue, Pan, Ziwei, Namburi, Sandeep, Pattison, Andrew, Posner, Atara, Balachander, Shiva, Paisie, Carolyn A., Reddi, Honey V, Rueter, Jens, Gill, Anthony J, Fox, Stephen, Raghav, Kanwal P.S., Flynn, William F, Tothill, Richard W., Li, Sheng, Karuturi, R. Krishna Murthy, George, Joshy

Publikováno v: In EBioMedicine November 2020 61

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.

Autor: Gherardin NA; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Victoria, Australia., Waldeck K; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Caneborg A; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Martelotto LG; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Balachander S; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Zethoven M; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Petrone PM; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Pattison A; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Quiñones-Parra SM; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia., Rossello F; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Posner A; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Wong A; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Weppler AM; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Hong A; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Jakrot V; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Raleigh J; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hatzimihalis A; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Neeson PJ; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Deleso P; Radiation Oncology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Johnston M; Radiation Oncology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Liverpool Hospital, Sydney, New South Wales, Australia., Chua M; Radiation Oncology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Becker JC; German Cancer Consortium (DKTK), Translational Skin Cancer Research, University Medicine Essen, Essen and DKFZ, Heidelberg, Germany., Sandhu S; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., McArthur GA; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Gill AJ; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical, Research and The University of Sydney, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; New South Wales Health Pathology, Sydney, New South Wales, Australia., Hicks RJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Cancer Imaging Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Godfrey DI; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Victoria, Australia., Tothill RW; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. rtothill@unimelb.edu.au.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2021 Jun; Vol. 9 (6), pp. 612-623. Date of Electronic Publication: 2021 Mar 05.